Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW 2,205.00
-65.00 (-2.86%)
At close: Mar 31, 2025, 3:30 PM KST
Genome & Company Revenue
In the year 2024, Genome & Company had annual revenue of 27.74B KRW with 94.07% growth. Genome & Company had revenue of 7.23B in the quarter ending December 31, 2024, with 102.14% growth.
Revenue
27.74B
Revenue Growth
+94.07%
P/S Ratio
2.58
Revenue / Employee
n/a
Employees
100
Market Cap
73.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |